Description

[vc_row][vc_column][vc_column_text]Cardiology and primary care physicians, nurse practitioners, physician assistants, pharmacists, and nurses who have a keen interest in FH can find updates in the Pharmacotherapeutic Management of Familial Hypercholesterolemia (FH) to be extremely useful. FH is the other name for type II hyperlipoproteinemia and it is defined as the autosomal disorder characterized by elevated plasma LDL-C levels in the absence of hypertriglyceridemia (or if triglycerides are elevated, they are so independently of FH). Practitioners would become eligible to describe the pathophysiology and genetics of FH, describe and apply presently available and emerging treatment options for FH, evaluate an appropriate treatment plan and suggest modifications for improvement, and to describe clinical and logistical challenges associated with FH.[/vc_column_text][/vc_column][/vc_row]